Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DoubleA
    Member
    • Jul 2010
    • 16

    #1

    attempting to sequence human MHC region

    I wanted to know if anyone has experience sequencing the human MHC region (~4 Mb). My plan is capture the region using a custom Agilent SureSelect kit (exons, intron, 5' and 3' UTRs). After masking the repetitive regions, I found that ~30,000 baits will cover the remaining 2 Mb of sequence at 1X tiling. We would like to generate libraries for both the 454 and GAIIX machines.

    Our next-generation core facility beta-tested Agilent's Human All-Exon SureSelect kit with good results except for the MHC region. Unfortunately, ~70% of the genes in this region were lacking sequence in one or more exons. I'm getting the feeling that it is probably impossible to sequence this region using a hybridization sequence capture approach. Any thoughts?

    Thanks,
    Double A
  • adamdeluca
    Member
    • Jul 2010
    • 95

    #2
    The Agilent All Exon kit only targets ~80% of coding refseq exons.
    Really quick numbers here: there are 560 baits in this kit that target the MHC region and ~1300 exons. The kit just doesn't target the region very well, your custom design will likely work fine.

    Comment

    • DoubleA
      Member
      • Jul 2010
      • 16

      #3
      Thanks for the information! That's really surprising. I think my 55000 baits will do a better job than their 560! How did you find out only 560 baits target the MHC region? Did you find a "BaitTiling_bed" file for Agilent's Human All-Exon SureSelect kit? I would really like to look at their bait layout on Santa Cruz's genome browser.

      Thanks,
      DoubleA

      Comment

      • adamdeluca
        Member
        • Jul 2010
        • 95

        #4
        You can get a bed file of the baits from the Agilents eArray site. I used bedTools to extract the baits targeting the MHC region. You could also upload the bed file from earray to UCSC as a custom track.

        Comment

        • DoubleA
          Member
          • Jul 2010
          • 16

          #5
          Wow! I just checked the bed file and you are correct. Many important genes do not have any baits. Thanks again for your help!

          Comment

          • NextGenSeq
            Senior Member
            • Apr 2009
            • 482

            #6
            Note Agilent is in the process of updating their "whole exome" enrichment kit. Apparently, a lot of people have complained at the large number of missed exons.

            Comment

            • KevinLam
              Senior Member
              • Nov 2009
              • 204

              #7
              Originally posted by NextGenSeq View Post
              Note Agilent is in the process of updating their "whole exome" enrichment kit. Apparently, a lot of people have complained at the large number of missed exons.
              by updates did you mean the new 50Mb kit?
              http://www.genomics.agilent.com/Gene...etail&PageID=4

              Just Launched:
              Agilent SureSelect Human All Exon 50Mb Kit; Provides the most complete definition of the human exome on the market!
              8/4/2010

              SANTA CLARA, Calif. And CAMBRIDGE, England, Aug. 4, 2010 –

              Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect Human All Exon 50 Mb Target Enrichment kit for next-generation DNA sequencing. The kit enables researchers to streamline experiments by sequencing the expressed genome while discarding regions that are not of interest.
              Last edited by KevinLam; 11-14-2010, 09:41 PM. Reason: added info
              http://kevin-gattaca.blogspot.com/

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                by SEQadmin2



                CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                Despite this, “CRISPR helped turn genome editing from a specialized technique into
                ...
                07-31-2026, 11:01 AM
              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Yesterday, 10:05 AM
              0 responses
              8 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 08-13-2026, 12:22 PM
              0 responses
              33 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 08-11-2026, 10:35 AM
              0 responses
              27 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 08-06-2026, 07:41 AM
              0 responses
              38 views
              0 reactions
              Last Post SEQadmin2  
              Working...